Insights from Italy: the Novara-COVID Score for rapid destination of COVID-19 patients at Emergency Department presentation

Gavelli, Francesco; Castello, Luigi Mario; Patrucco, Filippo; Bellan, Mattia; Sainaghi, Pier Paolo; Avanzi, Gian Carlo

doi:10.23736/s0026-4806.20.06609-4

Cited by 13 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[12][13][14] To accomplish this task, we proposed a clinical score, the novara-cOvid score, for rapid destination of cOvid patients at emergency department presentation. 15 This score was developed and adopted since the very first days of cOvid-19 pandemic in our University Hospital, to determine the intensity of care that should have been required by each cOvid patient.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical stability and in-hospital mortality prediction in COVID-19 patients presenting to the Emergency Department

et al. 2021

Self Cite

View full text Add to dashboard Cite

BacKGrOUnd: The novara-cOvid score was developed to help the emergency physician to decide which coronavirus disease (cOvid) patient required hospitalization at emergency department (ed) presentation and to which intensity of care. We aimed at evaluating its prognostic role. MeTHOdS: We retrospectively collected data of cOvid patients admitted to our ed between March 16 and april 22, 2020. The novara-cOvid score was systematically applied to all cOvid patients since its introduction in clinical practice and adopted to decide patients' destination. The ability of the novara-cOvid score to predict in-hospital clinical stability and in-hospital mortality were evaluated through multivariable logistic regression and cox regression hazard models, respectively. reSULTS: among the 480 cOvid patients admitted to the ed, 338 were hospitalized: the novara-cOvid score was 0-1 in 49.7%, 2 in 24.6%, 3 in 15.4% and 4-5 in 10.3% of patients. novara-cOvid score values of 3 and 4-5 were associated with lower clinical stability with adjusted odds ratios of 0.28 (0.13-0.59) and 0.03 (0.01-0.12), respectively. When inhospital mortality was evaluated, a significant difference emerged between scores of 0-1 and 2 vs. 3 and 4-5. in particular, the death adjusted hazard ratio for novara-cOvid scores of 3 and 4-5 were 2.6 (1.4-4.8) and 8.4 (4.7-15.2), respectively. cOncLUSiOnS: The novara-cOvid score reliably predicts in-hospital clinical instability and mortality of cOvid patients at ed presentation. This tool allows the emergency physician to detect patients at higher risk of clinical deterioration, suggesting a more aggressive therapeutic management from the beginning.

show abstract

Section: Discussionmentioning

confidence: 99%

“…After the first month since its introduction and its description in the literature, 15 we aimed at evaluating its efficacy in terms of prognostic role in clinical practice.…”

Section: Discussionmentioning

confidence: 99%

Clinical stability and in-hospital mortality prediction in COVID-19 patients presenting to the Emergency Department

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…16 Severe acute respiratory Syndrome coronavirus -2 (SARS-CoV-2) was recently identified first in Wuhan (China), and defined as responsible of clinical manifestations named coronavirus disease 2019 (cOvid-19). [17][18][19][20] current guidance from the World Health Organization (WHO) highlights asthmatics as a high-risk group for severe illness from SarS-cov-2. So far this suspect has not been confirmed by the most recently published studies: in fact, while asiatic reports identified a low prevalence of asthma in patients affected by SarS-cov-2, 21 in the USa the estimated prevalence was near to 20% in patients with laboratory-confirmed diagnosis of COVid-19.…”

mentioning

confidence: 99%